(AUGT) AIM Products Trust - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • • Defined Outcome

AUGT: Large Cap, Equity, Options, FLEX Options

The AUGT ETF Products Trust (NYSE ARCA: AUGT) is a defined outcome ETF designed to deliver returns tied to the performance of U.S. large-cap equities. Under normal market conditions, the fund allocates at least 80% of its net assets to financial instruments exhibiting economic characteristics similar to U.S. large-cap stocks. The investment strategy focuses on FLEX Options, which are customizable exchange-traded options designed to provide targeted exposure to the underlying ETF. These options are structured to offer defined outcomes, such as capped upside or buffered downside, within a specific time frame. The fund is non-diversified, meaning it can concentrate its holdings in a smaller number of securities, which may amplify risk and return potential.

As of the latest data, AUGT has an AUM of $32.42 million, indicating moderate scale in the ETF market. Its average trading volume over the past 20 days is 4,460 shares, reflecting limited liquidity compared to larger ETFs. From a technical perspective, the fund is currently trading at $30.87, slightly below its 20-day SMA of $31.53 but above its 200-day SMA of $30.34. This suggests near-term consolidation with a bullish longer-term trend. The 50-day SMA of $31.49 aligns closely with the 20-day SMA, indicating stability in the intermediate term. The ATR of 0.20 points to relatively low volatility, with average daily price movements remaining contained.

3-Month Forecast: - Price Support: $30.34 (200-day SMA) - Price Resistance: $31.53 (20-day SMA) - Expected Volatility: 0.20 (ATR) - Potential Price Movement: The fund is likely to trade within a narrow range between $30.34 and $31.53 over the next three months, with limited upside breakouts due to the defined outcome structure of its FLEX Options. - AUM Growth: Modest growth expected, driven by the appeal of defined outcome strategies in uncertain markets. - Volume Trends: Average daily volume may remain subdued, reflecting the funds niche strategy and limited market awareness. - Investor Interest: Steady inflows anticipated from investors seeking buffered equity exposure, though growth may be constrained by the funds smaller size and lower liquidity.

Additional Sources for AUGT ETF

AUGT ETF Overview

Market Cap in USD 30m
Category Defined Outcome
TER 0.74%
IPO / Inception 2023-07-31

AUGT ETF Ratings

Growth 5y 55.4%
Fundamental -
Dividend 0.0%
Rel. Strength Industry -0.34
Analysts -
Fair Price Momentum 28.54 USD
Fair Price DCF -

AUGT Dividends

No Dividends Paid

AUGT Growth Ratios

Growth Correlation 3m -6%
Growth Correlation 12m 93.5%
Growth Correlation 5y 97.4%
CAGR 5y 12.79%
CAGR/Max DD 5y 1.85
Sharpe Ratio 12m 1.52
Alpha 1.99
Beta 0.64
Volatility 20.44%
Current Volume 0.7k
Average Volume 20d 1.1k
What is the price of AUGT stocks?
As of March 15, 2025, the stock is trading at USD 30.38 with a total of 701 shares traded.
Over the past week, the price has changed by -1.61%, over one month by -4.98%, over three months by -3.62% and over the past year by +10.32%.
Is AIM Products Trust a good stock to buy?
Partly, yes. Based on ValueRay Analyses, AIM Products Trust (NYSE ARCA:AUGT) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 55.41 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AUGT as of March 2025 is 28.54. This means that AUGT is currently overvalued and has a potential downside of -6.06%.
Is AUGT a buy, sell or hold?
AIM Products Trust has no consensus analysts rating.
What are the forecast for AUGT stock price target?
According to ValueRays Forecast Model, AUGT AIM Products Trust will be worth about 31.8 in March 2026. The stock is currently trading at 30.38. This means that the stock has a potential upside of +4.77%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 31.8 4.8%